Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Macrophage Activator GcMAF-RF Enhances the Antitumor Effect of Karanahan Technology through Induction of M2-M1 Macrophage Reprogramming.
Ruzanova VS, Kirikovich SS, Levites EV, Proskurina AS, Dolgova EV, Ritter GS, Efremov YR, Dubatolova TD, Sysoev AV, Koleno DI, Ostanin AA, Chernykh ER, Bogachev SS. Ruzanova VS, et al. Among authors: ostanin aa. J Immunol Res. 2024 Feb 29;2024:7484490. doi: 10.1155/2024/7484490. eCollection 2024. J Immunol Res. 2024. PMID: 38455363 Free PMC article.
Exogenous allogenic fragmented double-stranded DNA is internalized into human dendritic cells and enhances their allostimulatory activity.
Alyamkina EA, Dolgova EV, Likhacheva AS, Rogachev VA, Sebeleva TE, Nikolin VP, Popova NA, Kiseleva EV, Orishchenko KE, Sakhno LV, Gel'fgat EL, Ostanin AA, Chernykh ER, Zagrebelniy SN, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: ostanin aa. Cell Immunol. 2010;262(2):120-6. doi: 10.1016/j.cellimm.2010.01.005. Epub 2010 Feb 1. Cell Immunol. 2010. PMID: 20170907
Effect of double-stranded DNA on maturation of dendritic cells in vitro.
Alyamkina EA, Leplina OY, Sakhno LV, Chernykh ER, Ostanin AA, Efremov YR, Shilov AG, Proskurina AS, Orishchenko KE, Dolgova EV, Rogachev VA, Nikolin VP, Popova NA, Zagrebelniy SN, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: ostanin aa. Cell Immunol. 2010;266(1):46-51. doi: 10.1016/j.cellimm.2010.08.011. Epub 2010 Sep 21. Cell Immunol. 2010. PMID: 20863487
A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.
Alyamkina EA, Nikolin VP, Popova NA, Dolgova EV, Proskurina AS, Orishchenko KE, Efremov YR, Chernykh ER, Ostanin AA, Sidorov SV, Ponomarenko DM, Zagrebelniy SN, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: ostanin aa. Genet Vaccines Ther. 2010 Nov 1;8:7. doi: 10.1186/1479-0556-8-7. Genet Vaccines Ther. 2010. PMID: 21040569 Free PMC article.
"Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNA.
Dolgova EV, Proskurina AS, Nikolin VP, Popova NA, Alyamkina EA, Orishchenko KE, Rogachev VA, Efremov YR, Dubatolova TD, Prokopenko AV, Chernykh ER, Ostanin AA, Taranov OS, Omigov VV, Zagrebelniy SN, Bogachev SS, Shurdov MA. Dolgova EV, et al. Among authors: ostanin aa. Gene. 2012 Mar 10;495(2):134-45. doi: 10.1016/j.gene.2011.12.032. Epub 2011 Dec 27. Gene. 2012. PMID: 22227496
Effects of human exogenous DNA on production of perforin-containing CD8+ cytotoxic lymphocytes in laboratory setting and clinical practice.
Alyamkina EA, Leplina OY, Ostanin AA, Chernykh ER, Nikolin VP, Popova NA, Proskurina AS, Gvozdeva TS, Dolgova EV, Orishchenko KE, Rogachev VA, Sidorov SV, Varaksin NA, Ryabicheva TG, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: ostanin aa. Cell Immunol. 2012 Mar-Apr;276(1-2):59-66. doi: 10.1016/j.cellimm.2012.04.004. Epub 2012 Apr 7. Cell Immunol. 2012. PMID: 22578800
Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA.
Dolgova EV, Efremov YR, Orishchenko KE, Andrushkevich OM, Alyamkina EA, Proskurina AS, Bayborodin SI, Nikolin VP, Popova NA, Chernykh ER, Ostanin AA, Taranov OS, Omigov VV, Minkevich AM, Rogachev VA, Bogachev SS, Shurdov MA. Dolgova EV, et al. Among authors: ostanin aa. Gene. 2013 Oct 10;528(2):74-83. doi: 10.1016/j.gene.2013.06.058. Epub 2013 Jul 30. Gene. 2013. PMID: 23911305
Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts.
Alyamkina EA, Nikolin VP, Popova NA, Minkevich AM, Kozel AV, Dolgova EV, Efremov YR, Bayborodin SI, Andrushkevich OM, Taranov OS, Omigov VV, Rogachev VA, Proskurina AS, Vereschagin EI, Kiseleva EV, Zhukova MV, Ostanin AA, Chernykh ER, Bogachev SS, Shurdov MA. Alyamkina EA, et al. Among authors: ostanin aa. Cancer Cell Int. 2015 Mar 19;15:32. doi: 10.1186/s12935-015-0180-6. eCollection 2015. Cancer Cell Int. 2015. PMID: 25798073 Free PMC article.
Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.
Proskurina AS, Gvozdeva TS, Alyamkina EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Zagrebelniy SN, Rogachev VA, Bogachev SS, Shurdov MA. Proskurina AS, et al. Among authors: ostanin aa. BMC Cancer. 2015 Mar 13;15:122. doi: 10.1186/s12885-015-1142-z. BMC Cancer. 2015. PMID: 25886605 Free PMC article. Clinical Trial.
107 results